Indometacin Galvex

Indometacin, the active ingredient in Indometacin Galvex, is a nonsteroidal anti-inflammatory drug presented as a rectal formulation for local administration. It is used to relieve inflammation and pain associated with rheumatic and musculoskeletal disorders in adult patients. It is indicated for the management of inflammatory joint conditions and acute gout attacks, providing analgesic and anti‑inflammatory effects.

GNH USA supplies Indometacin Galvex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable logistics for global healthcare providers.

Indometacin is employed to treat inflammatory and painful conditions affecting the musculoskeletal system.

- Rheumatoid arthritis: reduces joint inflammation and pain, improving function. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Gout: diminishes acute gouty arthritis attacks and associated swelling. - Ankylosing spondylitis: eases spinal inflammation and back pain. - Bursitis: lessens inflammation of bursae, restoring mobility. - Tendinitis: decreases tendon inflammation and related pain.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, abdominal pain. - Headache or dizziness. - Skin rash or mild itching. - Elevated liver enzymes without clinical symptoms. - Transient increase in blood pressure. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe renal impairment or failure. - Hepatotoxicity with jaundice. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or severe hypersensitivity reactions. - Cardiovascular events such as myocardial infarction.

Before prescribing Indometacin, clinicians should consider patient‑specific risk factors and monitor therapy appropriately.

- Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Monitor renal function: use caution in those with pre‑existing kidney disease. - Evaluate cardiovascular status: consider risk of thrombotic events in high‑risk patients. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to indometacin or other NSAIDs. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Indometacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: heightened lithium toxicity. - Methotrexate: enhanced methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): potential for increased bleeding. - Corticosteroids: additive gastrointestinal ulcer risk. - ACE inhibitors or diuretics: possible reduction in renal function.